Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 25Observational 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Recurrence 1NSCLC 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 406Surgical Procedures, Operative 152Radiotherapy 131Interviews as Topic 131Drug Therapy 123Observation 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 59Watchful Waiting 52Immunotherapy 51Bevacizumab 50Positron Emission Tomography Computed Tomography 46Ultrasonography 44Hematologic Tests 42Liquid Biopsy 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × dacomitinib × Clear all
NCT04768491 2021-02-24

Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC

Peking Union Medical College

Unknown
82 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT04575415 2020-10-20

BELLA

Guangdong Association of Clinical Trials

Unknown
272 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡